BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 32617052)

  • 1. Pheochromocytoma and Paraganglioma: From Epidemiology to Clinical Findings.
    Aygun N; Uludag M
    Sisli Etfal Hastan Tip Bul; 2020; 54(2):159-168. PubMed ID: 32617052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
    Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
    Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pheochromocytoma/Paraganglioma: A Poster Child for Cancer Metabolism.
    Tevosian SG; Ghayee HK
    J Clin Endocrinol Metab; 2018 May; 103(5):1779-1789. PubMed ID: 29409060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes.
    Turin CG; Crenshaw MM; Fishbein L
    Endocr Oncol; 2022 Jan; 2(1):R65-R77. PubMed ID: 37435466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas.
    Welander J; Söderkvist P; Gimm O
    Endocr Relat Cancer; 2011 Dec; 18(6):R253-76. PubMed ID: 22041710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genomic landscape of phaeochromocytoma.
    Flynn A; Benn D; Clifton-Bligh R; Robinson B; Trainer AH; James P; Hogg A; Waldeck K; George J; Li J; Fox SB; Gill AJ; McArthur G; Hicks RJ; Tothill RW
    J Pathol; 2015 May; 236(1):78-89. PubMed ID: 25545346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia Pathway Mutations in Pheochromocytomas and Paragangliomas.
    Amorim-Pires D; Peixoto J; Lima J
    Cytogenet Genome Res; 2016; 150(3-4):227-241. PubMed ID: 28231563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical management of paragangliomas.
    Corssmit EP; Romijn JA
    Eur J Endocrinol; 2014 Dec; 171(6):R231-43. PubMed ID: 25063320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience.
    Korpershoek E; Van Nederveen FH; Dannenberg H; Petri BJ; Komminoth P; Perren A; Lenders JW; Verhofstad AA; De Herder WW; De Krijger RR; Dinjens WN
    Ann N Y Acad Sci; 2006 Aug; 1073():138-48. PubMed ID: 17102080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Insights into Pheochromocytoma Biology: the Role of the Insulin - Like Growth Factor 1 (IGF1) System.
    Pennisi PA; Fernández MC; Martin A
    Pediatr Endocrinol Rev; 2020 Aug; 17(4):331-342. PubMed ID: 32780957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pheochromocytoma/Paraganglioma: Is This a Genetic Disorder?
    Fishbein L
    Curr Cardiol Rep; 2019 Jul; 21(9):104. PubMed ID: 31367972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.
    Comino-Méndez I; de Cubas AA; Bernal C; Álvarez-Escolá C; Sánchez-Malo C; Ramírez-Tortosa CL; Pedrinaci S; Rapizzi E; Ercolino T; Bernini G; Bacca A; Letón R; Pita G; Alonso MR; Leandro-García LJ; Gómez-Graña A; Inglada-Pérez L; Mancikova V; Rodríguez-Antona C; Mannelli M; Robledo M; Cascón A
    Hum Mol Genet; 2013 Jun; 22(11):2169-76. PubMed ID: 23418310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analysis of the SDHB and SDHD genes in pheochromocytomas and paragangliomas: identification of a novel nonsense mutation (Q168X) in the SDHB gene.
    Oishi Y; Nagai S; Yoshida M; Fujisawa S; Sazawa A; Shinohara N; Nonomura K; Matsuno K; Shimizu C
    Endocr J; 2010; 57(8):745-50. PubMed ID: 20505258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paragangliomas: update on differential diagnostic considerations, composite tumors, and recent genetic developments.
    Papathomas TG; de Krijger RR; Tischler AS
    Semin Diagn Pathol; 2013 Aug; 30(3):207-23. PubMed ID: 24144290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant pheochromocytomas and paragangliomas: a diagnostic challenge.
    Gimm O; DeMicco C; Perren A; Giammarile F; Walz MK; Brunaud L
    Langenbecks Arch Surg; 2012 Feb; 397(2):155-77. PubMed ID: 22124609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pheochromocytomas and Paragangliomas: New Developments with Regard to Classification, Genetics, and Cell of Origin.
    Koopman K; Gaal J; de Krijger RR
    Cancers (Basel); 2019 Jul; 11(8):. PubMed ID: 31362359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.
    Korpershoek E; Petri BJ; van Nederveen FH; Dinjens WN; Verhofstad AA; de Herder WW; Schmid S; Perren A; Komminoth P; de Krijger RR
    Endocr Relat Cancer; 2007 Jun; 14(2):453-62. PubMed ID: 17639058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pheochromocytoma of the Organ Zuckerkandl.
    Lee C; Chang E; Gimenez J; McCarron R
    J La State Med Soc; 2017; 169(2):53. PubMed ID: 28414676
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.